Prevalence and Spread of Multidrug Resistant Escherichia coli Isolates Among Nursing Home Residents in the Southern Part of the Netherlands

Journal of the American Medical Directors Association

Volumn 14, Issue 3, 2013, Pages 199-203

  Van der Donk, C F M ^a,b   Schols, J M G A ^b,c   Driessen, C J ^d   Hagenouw, R G P ^e   Meulendijks, A ^f   Stobberingh, E E ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Vivre   (Netherlands)

^d Expertise Behandel Centrum Camillus   (Netherlands)

^e Zorgcentrum Sevagram   (Netherlands)

^f Land Van Horne   (Netherlands)

Author keywords

Defined daily dose; Empiric treatment; Fluoroquinolones; ST131

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; FOLIC ACID ANTAGONIST; NITROFURANTOIN; NORFLOXACIN; TRIMETHOPRIM;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM ISOLATE; DRUG TREATMENT FAILURE; DRUG USE; ESCHERICHIA COLI; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NETHERLANDS; NURSING HOME; NURSING HOME PATIENT; OBSERVATIONAL STUDY; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; URINALYSIS; URINE INCONTINENCE; VULNERABLE POPULATION;

EID: 84874268982     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2012.09.026     Document Type: Article

References (39)

1. Nicolle L.E., Strausbaugh L.J., Garibaldi R.A. Infections and antibiotic resistance in nursing homes. Clin Microbiol Rev 1996, 9:1-17.
2. Tal S., Guller V., Levi S., et al. Profile and prognosis of febrile elderly patients with bacteremic urinary tract infection. J Infect 2005, 50:296-305.
3. Koch A.M., Eriksen H.M., Elstrom P., et al. Severe consequences of healthcare-associated infections among residents of nursing homes: A cohort study. J Hosp Infect 2009, 71:269-274.
4. Nicolle L.E., Bentley D.W., Garibaldi R., et al. Antimicrobial use in long-term-care facilities. SHEA Long-Term-Care Committee. Infect Control Hosp Epidemiol 2000, 21:537-545.
5. Nicolle L.E. Resistant pathogens in urinary tract infections. J Am Geriatr Soc 2002, 50:S230-S235.
6. Oliphant C.M., Green G.M. Quinolones: A comprehensive review. Am Fam Physician 2002, 65:455-464.
7. Goossens H., Ferech M., Vander Stichele R., et al. Outpatient antibiotic use in Europe and association with resistance: A cross-national database study. Lancet 2005, 365:579-587.
8. Rooney P.J., O'Leary M.C., Loughrey A.C., et al. Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. J Antimicrob Chemother 2009, 64:635-641.
9. Johnson J.R., Johnston B., Clabots C., et al. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 2010, 51:286-294.
10. Croxall G., Hale J., Weston V., et al. Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings. J Antimicrob Chemother 2011, 66:2501-2508.
11. Matthews S.J., Lancaster J.W. Urinary tract infections in the elderly population. Am J Geriatr Pharmacother 2011, 9:286-309.
12. Chami K., Gavazzi G., Carrat F., et al. Burden of infections among 44,869 elderly in nursing homes: A cross-sectional cluster nationwide survey. J Hosp Infect 2011, 79:254-259.
13. Lee S.S., Kim Y., Chung D.R. Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis. J Infect 2011, 62:159-164.
14. Hounsom L., Grayson K., Melzer M. Mortality and associated risk factors in consecutive patients admitted to a UK NHS trust with community acquired bacteraemia. Postgrad Med J 2011, 87:757-762.
15. Yamamoto S., Tsukamoto T., Terai A., et al. Genetic evidence supporting the fecal-perineal-urethral hypothesis in cystitis caused by Escherichia coli. J Urol 1997, 157:1127-1129.
16. Beerepoot M.A., den Heijer C.D., Penders J., et al. Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clin Microbiol Infect 2012, 18:E84-E90.
17. Xie C., Taylor D.M., Howden B.P., et al. Comparison of the bacterial isolates and antibiotic resistance patterns of elderly nursing home and general community patients. Intern Med J 2012, 42:e157-e164.
18. Nys S., van Merode T., Bartelds A.I., et al. Antibiotic treatment and resistance of unselected uropathogens in the elderly. Int J Antimicrob Agents 2006, 27:236-241.
19. EUCAST. Breakpoint tables for interpretation of MICs and zone diameters, version 1.3. January 2011. Available at: Accessed October 31, 2012. http://www.eucast.org/antimicrobial_susceptibility_testing/previous_versions_of_tables/.
20. NVMM. NVMM Guideline - Laboratory detection of highly resistant microorganisms (HRMO) - version 1.0. Available at: Accessed October 31, 2012. http://www.nvmm.nl/richtlijnen/hrmo-laboratory-detection-highly-resistant-microorganisms.
21. Saladin M., Cao V.T., Lambert T., et al. Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol Lett 2002, 209:161-168.
22. Pitout J.D., Hossain A., Hanson N.D. Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp. J Clin Microbiol 2004, 42:5715-5721.
23. Pallecchi L., Malossi M., Mantella A., et al. Detection of CTX-M-type beta-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru. Antimicrob Agents Chemother 2004, 48:4556-4561.
24. Meex C, Melin P, Docquier JD, et al. Presence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in fecal flora of patients from general practice. Presented at: ECCMID 2008-European Congress of Clinical Microbiology and Infectious Diseases; April 19-22, 2008; Barcelona, Spain.
25. Ribot E.M., Fair M.A., Gautom R., et al. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis 2006, 3:59-67.
26. Wirth T., Falush D., Lan R., et al. Sex and virulence in Escherichia coli: An evolutionary perspective. Mol Microbiol 2006, 60:1136-1151.
27. University College Cork. Escherichia coli MLST database. Available at: mlst.ucc.ie/mlst/dbs/Ecoli. Accessed July 6, 2012.
28. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2012. Available at: Accessed June 25, 2012. http://www.whocc.no/atc_ddd_index/.
29. Gupta K., Hooton T.M., Naber K.G., et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011, 52:e103-e120.
30. den Heijer C.D., Donker G.A., Maes J., et al. Antibiotic susceptibility of unselected uropathogenic Escherichia coli from female Dutch general practice patients: A comparison of two surveys with a 5 year interval. J Antimicrob Chemother 2010, 65:2128-2133.
31. SWAB. Nethmap 2011-Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. 2011. Available at: Accessed October 31, 2012. http://www.swab.nl/swab/cms3.nsf/viewdoc/20BCD3983B5C390AC12575850031D33D.
32. McClean P., Hughes C., Tunney M., et al. Antimicrobial prescribing in European nursing homes. J Antimicrob Chemother 2011, 66:1609-1616.
33. Charalabopoulos K., Karachalios G., Baltogiannis D., et al. Penetration of antimicrobial agents into the prostate. Chemotherapy 2003, 49:269-279.
34. Raz R. Fosfomycin: An old-new antibiotic. Clin Microbiol Infect 2012, 18:4-7.
35. Tartof S.Y., Solberg O.D., Manges A.R., et al. Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing. J Clin Microbiol 2005, 43:5860-5864.
36. Gibreel T.M., Dodgson A.R., Cheesbrough J., et al. Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. J Antimicrob Chemother 2012, 67:346-356.
37. Lindsey R.L., Frye J.G., Thitaram S.N., et al. Characterization of multidrug-resistant Escherichia coli by antimicrobial resistance profiles, plasmid replicon typing, and pulsed-field gel electrophoresis. Microb Drug Resist 2011, 17:157-163.
38. Jepson R.G., Craig J.C. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2008, CD001321.
39. Beerepoot M.A.J., Ter Riet G., Nys S., et al. Lactobacilli vs antibiotics to prevent urinary tract infections: A randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med 2012, 172:704-712.